These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23600958)

  • 1. Pyranoflavones: a group of small-molecule probes for exploring the active site cavities of cytochrome P450 enzymes 1A1, 1A2, and 1B1.
    Liu J; Taylor SF; Dupart PS; Arnold CL; Sridhar J; Jiang Q; Wang Y; Skripnikova EV; Zhao M; Foroozesh M
    J Med Chem; 2013 May; 56(10):4082-92. PubMed ID: 23600958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives.
    Shimada T; Tanaka K; Takenaka S; Murayama N; Martin MV; Foroozesh MK; Yamazaki H; Guengerich FP; Komori M
    Chem Res Toxicol; 2010 Dec; 23(12):1921-35. PubMed ID: 21053930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons.
    Shimada T; Guengerich FP
    Chem Res Toxicol; 2006 Feb; 19(2):288-94. PubMed ID: 16485905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different mechanisms for inhibition of human cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic inhibitors.
    Shimada T; Murayama N; Okada K; Funae Y; Yamazaki H; Guengerich FP
    Chem Res Toxicol; 2007 Mar; 20(3):489-96. PubMed ID: 17291012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of flavone propargyl ethers as potent and selective inhibitors of cytochrome P450 enzymes 1A1 and 1A2.
    Sridhar J; Ellis J; Dupart P; Liu J; Stevens CL; Foroozesh M
    Drug Metab Lett; 2012; 6(4):275-84. PubMed ID: 23506553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectral modification and catalytic inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2A6, and 2A13 by four chemopreventive organoselenium compounds.
    Shimada T; Murayama N; Tanaka K; Takenaka S; Guengerich FP; Yamazaki H; Komori M
    Chem Res Toxicol; 2011 Aug; 24(8):1327-37. PubMed ID: 21732699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethynylflavones, highly potent, and selective inhibitors of cytochrome P450 1A1.
    Goyal N; Liu J; Lovings L; Dupart P; Taylor S; Bellow S; Mensah L; McClain E; Dotson B; Sridhar J; Zhang X; Zhao M; Foroozesh M
    Chem Res Toxicol; 2014 Aug; 27(8):1431-9. PubMed ID: 25033111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 7-Ethynylcoumarins: selective inhibitors of human cytochrome P450s 1A1 and 1A2.
    Liu J; Nguyen TT; Dupart PS; Sridhar J; Zhang X; Zhu N; Stevens CL; Foroozesh M
    Chem Res Toxicol; 2012 May; 25(5):1047-57. PubMed ID: 22443586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active Site Mutations as a Suitable Tool Contributing to Explain a Mechanism of Aristolochic Acid I Nitroreduction by Cytochromes P450 1A1, 1A2 and 1B1.
    Milichovský J; Bárta F; Schmeiser HH; Arlt VM; Frei E; Stiborová M; Martínek V
    Int J Mol Sci; 2016 Feb; 17(2):213. PubMed ID: 26861298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1.
    Shimada T; Yamazaki H; Foroozesh M; Hopkins NE; Alworth WL; Guengerich FP
    Chem Res Toxicol; 1998 Sep; 11(9):1048-56. PubMed ID: 9760279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theoretical investigation of differences in nitroreduction of aristolochic acid I by cytochromes P450 1A1, 1A2 and 1B1.
    Jerabek P; Martinek V; Stiborova M
    Neuro Endocrinol Lett; 2012; 33 Suppl 3():25-32. PubMed ID: 23353840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Ligand-Based Drug Design. Discovery of 4-Trifluoromethyl-7,8-pyranocoumarin as a Selective Inhibitor of Human Cytochrome P450 1A2.
    Liu J; Pham PT; Skripnikova EV; Zheng S; Lovings LJ; Wang Y; Goyal N; Bellow SM; Mensah LM; Chatters AJ; Bratton MR; Wiese TE; Zhao M; Wang G; Foroozesh M
    J Med Chem; 2015 Aug; 58(16):6481-93. PubMed ID: 26222195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactivation of diesel exhaust particle extracts and their major nitrated polycyclic aromatic hydrocarbon components, 1-nitropyrene and dinitropyrenes, by human cytochromes P450 1A1, 1A2, and 1B1.
    Yamazaki H; Hatanaka N; Kizu R; Hayakawa K; Shimada N; Guengerich FP; Nakajima M; Yokoi T
    Mutat Res; 2000 Dec; 472(1-2):129-38. PubMed ID: 11113705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice.
    Shimada T; Inoue K; Suzuki Y; Kawai T; Azuma E; Nakajima T; Shindo M; Kurose K; Sugie A; Yamagishi Y; Fujii-Kuriyama Y; Hashimoto M
    Carcinogenesis; 2002 Jul; 23(7):1199-207. PubMed ID: 12117779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
    Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
    Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ortho-Methylarylamines as Time-Dependent Inhibitors of Cytochrome P450 1A1 Enzyme.
    Sridhar J; Liu J; Komati R; Schroeder R; Jiang Q; Tram P; Riley K; Foroozesh M
    Drug Metab Lett; 2017; 10(4):270-277. PubMed ID: 28000546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cytochrome p450 enzymes by quinones and anthraquinones.
    Sridhar J; Liu J; Foroozesh M; Klein Stevens CL
    Chem Res Toxicol; 2012 Feb; 25(2):357-65. PubMed ID: 22185593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Cloning, Tissue Distribution, and Functional Characterization of Marmoset Cytochrome P450 1A1, 1A2, and 1B1.
    Uehara S; Uno Y; Inoue T; Sasaki E; Yamazaki H
    Drug Metab Dispos; 2016 Jan; 44(1):8-15. PubMed ID: 26502772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1.
    Kim JH; Stansbury KH; Walker NJ; Trush MA; Strickland PT; Sutter TR
    Carcinogenesis; 1998 Oct; 19(10):1847-53. PubMed ID: 9806168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors.
    Kim S; Ko H; Park JE; Jung S; Lee SK; Chun YJ
    J Med Chem; 2002 Jan; 45(1):160-4. PubMed ID: 11754588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.